BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for FERRING PHARMACEUTICALS INC. · biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · $50,000.00 income · posted Apr 18, 2025

Lobbying activity 2

Health Issues

Issues related to microbiome, oncology, & fertility Issues related to formulary tier status

Veterans

Issues related to veteran's care and veteran's reproductive care

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.